Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast in Ankylosing Spondylitis (START)
NCT00944658Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Aug 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apremilast in ankylosing spondylitis (AS), sponsored by Imperial College London. Started Aug 2009; status: completed.
02
Drugs
apremilast
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT00944658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00944658.